Vasomotor Rhinitis

01/01/2009 - "Intranasal azelastine hydrochloride (Astelin, Meda Pharmaceuticals, Somerset, NJ, USA) is a first-line treatment for allergic and non-allergic vasomotor rhinitis with well-established therapeutic efficacy and safety. "
03/01/2001 - "The present study demonstrates the efficacy of azelastine nasal spray in the treatment of vasomotor rhinitis. "
03/01/2001 - "Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo."
03/01/2001 - "We performed a multicenter randomized double-blind placebo-controlled study of the efficacy and tolerance of azelastine nasal spray in 89 adult patients with vasomotor rhinitis (confirmed by negative Phadiatop). "
11/01/2013 - "Total vasomotor rhinitis symptoms scores were substantially reduced in the azelastine-treated subjects compared with the control group. "

12/01/1988 - "Additionally, capsaicin, which in high concentration selectively blocks sensory C-fibers, was found to be effective in treatment of hyperreactive rhinopathy (vasomotor rhinitis). "
02/01/1999 - "The results of this preliminary study lead us to consider that an imbalance in the autonomic innervation of the mucosa of the middle ear may play a role in the aetiology of SOM as in vasomotor rhinitis, and capsaicin may be an alternative in the treatment."
01/01/1991 - "In the present study, we studied the effects of 15 micrograms capsaicin suspended in 100 microliters solution in patients with known vasomotor rhinitis. "
01/01/2014 - "Intranasal capsaicin in management of nonallergic (vasomotor) rhinitis."
07/01/1997 - "Wolf and others have demonstrated in human subjects that vasomotor rhinitis can be blocked up to 1 year by a series of intranasal capsaicin applications. "

01/01/2012 - "The objective of this work was to study the feasibility and effectiveness of the cavitational low-frequency ultrasound treatment of vasomotor rhinitis in combination with the application of topical corticosteroids. "
01/01/2012 - "The data obtained indicate that the low-frequency cavitational treatment of intranasal mucosa in combination with the application of topical corticosteroids may be recommended as an efficatious method for the treatment of vasomotor rhinitis."
01/01/2009 - "The treatment of vasomotor rhinitis with intranasal corticosteroids."
01/01/1964 - "[OUR EXPERIENCE ON TREATMENT OF VASOMOTOR RHINITIS WITH LOCAL INFILTRATIONS OF CORTICOSTEROIDS]."
01/01/2012 - "[Ultrasonic therapy of vasomotor rhinitis in combination with the application of topical corticosteroids]."

09/01/1987 - "Topical nasal ipratropium bromide is highly effective in the control of the rhinorrhea of vasomotor rhinitis. "
09/01/1987 - "A randomized, double-blind, placebo-controlled trial of ipratropium bromide nasal spray was performed with 25 patients with vasomotor rhinitis. "
11/01/1986 - "A trial of intranasal Atrovent versus placebo in the treatment of vasomotor rhinitis."
12/01/1983 - "A therapeutical trial with ipratropium is appropriate in the management of severe rhinorrhoea in patients with vasomotor rhinitis."
12/01/1983 - "Ipratropium administered in the form of a nasal spray was compared with placebo in 30 patients with vasomotor rhinitis in a double-blind cross-over trial. "

01/01/2004 - "While clinical studies of azelastine have demonstrated that this drug is highly efficacious in the treatment of all the symptoms of vasomotor rhinitis, mechanistic studies have demonstrated that azelastine has potent anti-inflammatory effects (in particular attenuation of the expression and synthesis of pro-inflammatory cytokines, leukotrienes, and cell adhesion molecules), which are likely to contribute to its clinical efficacy. "
03/01/2003 - "Azelastine has established antiallergic and anti-inflammatory effects that are unrelated to H1-receptor antagonism, including inhibitory effects on the synthesis of leukotrienes, kinins, and cytokines; the generation of superoxide free radicals; and the expression of the intercellular adhesion molecule 1. Azelastine is available in the United States as a nasal spray formulation (Astelin) and is approved for treatment of seasonal allergic rhinitis and nonallergic vasomotor rhinitis. "

01/01/2004 - "While clinical studies of azelastine have demonstrated that this drug is highly efficacious in the treatment of all the symptoms of vasomotor rhinitis, mechanistic studies have demonstrated that azelastine has potent anti-inflammatory effects (in particular attenuation of the expression and synthesis of pro-inflammatory cytokines, leukotrienes, and cell adhesion molecules), which are likely to contribute to its clinical efficacy. "
03/01/2003 - "Azelastine has established antiallergic and anti-inflammatory effects that are unrelated to H1-receptor antagonism, including inhibitory effects on the synthesis of leukotrienes, kinins, and cytokines; the generation of superoxide free radicals; and the expression of the intercellular adhesion molecule 1. Azelastine is available in the United States as a nasal spray formulation (Astelin) and is approved for treatment of seasonal allergic rhinitis and nonallergic vasomotor rhinitis. "

07/01/2011 - "Olopatadine 0.6% nasal spray protects from vasomotor challenge in patients with severe vasomotor rhinitis."
03/01/2011 - "Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis."
03/01/2011 - "Olopatadine hydrochloride nasal spray 0.6% (OLO) and azelastine nasal spray 137 micrograms (AZE) are effective in treating allergic rhinitis and AZE is indicated for nonallergic vasomotor rhinitis (VMR). "

01/01/2004 - "While clinical studies of azelastine have demonstrated that this drug is highly efficacious in the treatment of all the symptoms of vasomotor rhinitis, mechanistic studies have demonstrated that azelastine has potent anti-inflammatory effects (in particular attenuation of the expression and synthesis of pro-inflammatory cytokines, leukotrienes, and cell adhesion molecules), which are likely to contribute to its clinical efficacy. "

01/01/2009 - "Interpreting this information allows one to conclude that antihistamines may be potentially effective agents in vasomotor rhinitis, and are more likely to be so when administered intranasally, despite the fact that data documenting this beneficial effect are sparse."
01/01/2009 - "The role of antihistamines in the treatment of vasomotor rhinitis."
11/01/1975 - "The beneficial effect of some antihistamines in vasomotor rhinitis may thus be due to their anticholinergic properties."
01/01/2004 - "Although treatment of vasomotor rhinitis involves the use of either intranasal corticosteroids or antihistamines, the corticosteroids are generally not effective in treatment of all the symptoms of vasomotor rhinitis and have generally been shown to be effective in patients with eosinophilia. "
06/01/1976 - "For treatment of patients with vasomotor rhinitis, intra-nasal BDA in a daily dose of 200 mug can be recommended when antihistamines, sympathomimetic drugs and sodium cromoglycate are not sufficiently effective."

03/01/2001 - "The H(1) antagonist azelastine is used in nasal sprays for the treatment of allergic rhinitis, but its therapeutic efficacy in vasomotor rhinitis is unknown. "

01/01/1989 - "The efficacy of laser therapy of vasomotor rhinitis became optimal on irradiation day 6 or 7 and reached a maximum on day 10."
09/01/1990 - "[Functional methods of study in the evaluation of the effectiveness of laser therapy of vasomotor rhinitis and some forms of prosopalgia]."
01/01/2013 - "[The complications of laser surgery for the treatment of chronic vasomotor rhinitis]."
05/01/1991 - "Magnet-laser therapy was used to treat vasomotor rhinitis in 90 patients. "
01/01/1989 - "[Indicators of the activity of the immune system during laser therapy of vasomotor rhinitis]."

04/01/1984 - "This cryotherapy technique provides significantly improved results in the treatment of vasomotor rhinitis when proper patient selection and technique are utilized."
04/01/1984 - "Cryotherapy for chronic vasomotor rhinitis: technique and patient selection for improved results."
11/11/1985 - "This article reviews the clinical and pathological features, differential diagnosis, and management of vasomotor rhinitis and reports a study of 110 patients treated between 1979 and 1983 by the application of cryotherapy to the mucosa overlying the inferior turbinate bones."
04/01/1984 - "Indications for cryotherapy included: failure of medical therapy in anatomically normal patients with mucosal disease caused only by vasomotor rhinitis. "
04/02/1982 - "Experience with cryotherapy of vasomotor rhinitis is reported. "

01/01/2008 - "The results of placebo-controlled randomized trial of effectiveness of haloinhalation treatment with application of individual inhaler Haloneb in 125 patients with allergic and vasomotor rhinitis demonstrated high efficacy of the method. "

01/01/2000 - "The conclusion is made that low-energy laser radiation is effective in correction of microcirculatory disorders and tissue mechanisms of homeostasis in children with neurovegetative vasomotor rhinitis."
01/01/2000 - "Turbinated bone's mucosa of 46 children aged 6 to 15 years was exposed to radiation of low-energy laser for neurovegetative vasomotor rhinitis. "
01/01/2000 - "[Correction of microcirculatory disorders with low-energy laser radiation in children with vasomotor rhinitis]."
11/01/1986 - "[Microcirculation in patients with vasomotor rhinitis and its dynamics before and after the therapeutic use of laser irradiation]."
03/01/1991 - "The specific effect of a laser beam on microcirculation suggests that laser surgery can be viewed as a pathogenetic method of therapy of vasomotor rhinitis. "

07/01/2011 - "The aim of the work was to assess the treatment efficiency in patients with allergic and non-allergic vasomotor rhinitis after cryoablation procedures. "
07/01/1990 - "The authors expose usefulness of the cryosurgery for the management in vasomotor rhinitis. "
07/01/1990 - "[Cryosurgery for the treatment of vasomotor rhinitis]."
07/01/1983 - "Clinical experience with a newly designed device for cryosurgery on autonomic nerves in cases of vasomotor rhinitis is reported. "
04/02/1982 - "[Cryosurgery in vasomotor rhinitis]."